
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 338038
[patent_doc_number] => 07504379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Protection of cardiac myocardium'
[patent_app_type] => utility
[patent_app_number] => 11/129076
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 13647
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129076 | Protection of cardiac myocardium | May 12, 2005 | Issued |
Array
(
[id] => 6254635
[patent_doc_number] => 20100028917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'A NEUROGLOBIN ENZYME-LINKED IMMUNOSORBENT ASSAY KIT AND THE USE OF IT'
[patent_app_type] => utility
[patent_app_number] => 11/913134
[patent_app_country] => US
[patent_app_date] => 2005-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6525
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913134 | A NEUROGLOBIN ENZYME-LINKED IMMUNOSORBENT ASSAY KIT AND THE USE OF IT | Apr 29, 2005 | Abandoned |
Array
(
[id] => 5028892
[patent_doc_number] => 20070270339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Use of GPCR54 Ligands for the Treatment of Infertility'
[patent_app_type] => utility
[patent_app_number] => 11/547293
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19234
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547293 | Use of GPCR54 Ligands for the Treatment of Infertility | Apr 18, 2005 | Abandoned |
Array
(
[id] => 4927860
[patent_doc_number] => 20080167223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity'
[patent_app_type] => utility
[patent_app_number] => 11/547735
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14563
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547735
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547735 | Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity | Apr 12, 2005 | Abandoned |
Array
(
[id] => 7004574
[patent_doc_number] => 20050169887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Method and pharmaceutical composition for treating inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/090188
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23995
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169887.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090188 | Method and pharmaceutical composition for treating inflammation | Mar 27, 2005 | Issued |
Array
(
[id] => 4977883
[patent_doc_number] => 20070219116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Follicle Stimulating Hormone Superagonists'
[patent_app_type] => utility
[patent_app_number] => 10/593466
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 16625
[patent_no_of_claims] => 137
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593466 | Follicle Stimulating Hormone Superagonists | Mar 17, 2005 | Abandoned |
Array
(
[id] => 7250018
[patent_doc_number] => 20050272635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Use of corticotroph-derivced glycoprotein hormone to treat liver steatosis'
[patent_app_type] => utility
[patent_app_number] => 11/073222
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4424
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272635.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073222 | Use of corticotroph-derivced glycoprotein hormone to treat liver steatosis | Mar 3, 2005 | Abandoned |
Array
(
[id] => 859783
[patent_doc_number] => 07371373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'HSA-free formulations of interferon-β'
[patent_app_type] => utility
[patent_app_number] => 11/062146
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12589
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11062146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/062146 | HSA-free formulations of interferon-β | Feb 17, 2005 | Issued |
Array
(
[id] => 5821049
[patent_doc_number] => 20060025362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/059292
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15017
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11059292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/059292 | Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation | Feb 15, 2005 | Abandoned |
Array
(
[id] => 10627770
[patent_doc_number] => 09345911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Methods of inducing melanogenesis in a subject'
[patent_app_type] => utility
[patent_app_number] => 11/659178
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12179
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11659178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659178 | Methods of inducing melanogenesis in a subject | Feb 10, 2005 | Issued |
Array
(
[id] => 6996278
[patent_doc_number] => 20050136056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Pharmaceutical composition for the treatment of thrombocytopenia'
[patent_app_type] => utility
[patent_app_number] => 11/044198
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6906
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136056.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044198 | Pharmaceutical composition for the treatment of thrombocytopenia | Jan 27, 2005 | Abandoned |
Array
(
[id] => 228703
[patent_doc_number] => 07601516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility'
[patent_app_type] => utility
[patent_app_number] => 11/045022
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15039
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601516.pdf
[firstpage_image] =>[orig_patent_app_number] => 11045022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/045022 | Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility | Jan 26, 2005 | Issued |
Array
(
[id] => 7196692
[patent_doc_number] => 20050164364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Human heme-regulated initiation factor 2-alpha kinase'
[patent_app_type] => utility
[patent_app_number] => 11/042643
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7974
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164364.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042643
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042643 | Human heme-regulated initiation factor 2-alpha kinase | Jan 23, 2005 | Issued |
| 11/039397 | Novel human EGF-family proteins and polynucleotides encoding the same | Jan 19, 2005 | Abandoned |
Array
(
[id] => 4820181
[patent_doc_number] => 20080226554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Methods For Detecting Markers Associated With Endometrial Disease or Phase'
[patent_app_type] => utility
[patent_app_number] => 10/584207
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 55779
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584207 | Methods For Detecting Markers Associated With Endometrial Disease or Phase | Dec 20, 2004 | Abandoned |
Array
(
[id] => 481623
[patent_doc_number] => 07220413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Pharmaceutical composition containing inhibitors of interferon-γ'
[patent_app_type] => utility
[patent_app_number] => 11/014209
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2471
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220413.pdf
[firstpage_image] =>[orig_patent_app_number] => 11014209
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/014209 | Pharmaceutical composition containing inhibitors of interferon-γ | Dec 16, 2004 | Issued |
Array
(
[id] => 5237138
[patent_doc_number] => 20070129295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Method for purifying fsh'
[patent_app_type] => utility
[patent_app_number] => 10/581172
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8016
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581172 | Method for purifying FSH | Dec 15, 2004 | Issued |
Array
(
[id] => 7045590
[patent_doc_number] => 20050250185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'OGH fusion polypeptides and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/008727
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7343
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250185.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008727 | OGH fusion polypeptides and therapeutic uses thereof | Dec 8, 2004 | Abandoned |
Array
(
[id] => 849180
[patent_doc_number] => 07381698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'Methods for treatment of acute pancreatitis'
[patent_app_type] => utility
[patent_app_number] => 11/007490
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4881
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381698.pdf
[firstpage_image] =>[orig_patent_app_number] => 11007490
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/007490 | Methods for treatment of acute pancreatitis | Dec 7, 2004 | Issued |
Array
(
[id] => 7005704
[patent_doc_number] => 20050171017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Methods for treating inflammation using thyroid stimulating hormone'
[patent_app_type] => utility
[patent_app_number] => 11/005591
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16660
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171017.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005591 | Methods for treating inflammation using thyroid stimulating hormone | Dec 5, 2004 | Abandoned |